Transformation of neuraminidase-treated lymphocytes by soybean agglutinin

Proc Natl Acad Sci U S A. 1973 Sep;70(9):2515-8. doi: 10.1073/pnas.70.9.2515.

Abstract

Transformation of mouse-spleen lymphocytes in the presence of soybean agglutinin is markedly enhanced after their treatment with neuraminidase (EC 3.2.1.18). Incubation of the cells with the enzyme also facilitates their agglutination by the lectin. The soybean agglutinin-induced agglutination and transformation is inhibited specifically by N-acetyl-D-galactosamine. New specific binding sites for soybean agglutinin were shown to appear after neuraminidase treatment. It is postulated that the transformation of neuraminidase-treated mouse-spleen lymphocytes induced by soybean agglutinin is caused by the binding of the lectin to galactosyl residues exposed by the action of neuraminidase on the cell membrane.

MeSH terms

  • Animals
  • Binding Sites
  • Cell Line
  • Cell Membrane / metabolism
  • Cricetinae
  • Embryo, Mammalian
  • Galactosamine / pharmacology
  • Galactose / pharmacology
  • Glucosamine / pharmacology
  • Glucose / pharmacology
  • Glycine max
  • Iodine Isotopes
  • Kidney
  • Lectins / metabolism
  • Lectins / pharmacology*
  • Lymphocyte Activation / drug effects*
  • Lymphocytes / metabolism
  • Mannose / pharmacology
  • Mice
  • Neuraminic Acids / pharmacology
  • Neuraminidase / antagonists & inhibitors
  • Neuraminidase / pharmacology*
  • Plant Lectins
  • Spleen / cytology
  • Spleen / immunology
  • Thymidine / metabolism
  • Tritium

Substances

  • Iodine Isotopes
  • Lectins
  • Neuraminic Acids
  • Plant Lectins
  • Tritium
  • Galactosamine
  • Neuraminidase
  • Glucose
  • Glucosamine
  • Mannose
  • Thymidine
  • Galactose